Email this article A clinical case of inhibitor development in a patient with type 3 von Willebrand disease and the use of emicizumab as hemostatic treatment - PDF (Russian)
Copyright (c) 2026 «D. Rogachev NMRCPHOI»
This work is licensed under a Creative Commons Attribution 4.0 International License.